86 results for “transfer pricing”+ Section 151(2)clear
Sorted by relevance
Key Topics
Showing 1–20 of 86 · Page 1 of 5
Bench: Shri Mahavir Prasad, Judicial Memebr & Shri Waseem Ahmed, Accountant Memebr
section 115JB(2). 13. On the facts and circumstances of the case and in law, the CIT(A) erred in deleting the disallowance of proportionate R & D revenue expenses incurred by the assessee on behalf of Sun Pharmaceutical Industries and Sun Pharma Sikkim the firms without appreciating the facts and reasons mentioned by the AO in the assessment order